1. Home
  2. EVAX vs LGCB Comparison

EVAX vs LGCB Comparison

Compare EVAX & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • LGCB
  • Stock Information
  • Founded
  • EVAX 2008
  • LGCB 2011
  • Country
  • EVAX Denmark
  • LGCB Japan
  • Employees
  • EVAX N/A
  • LGCB N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • LGCB
  • Sector
  • EVAX Health Care
  • LGCB
  • Exchange
  • EVAX Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • EVAX 8.7M
  • LGCB 9.0M
  • IPO Year
  • EVAX 2021
  • LGCB 2023
  • Fundamental
  • Price
  • EVAX $2.62
  • LGCB $0.24
  • Analyst Decision
  • EVAX Strong Buy
  • LGCB
  • Analyst Count
  • EVAX 3
  • LGCB 0
  • Target Price
  • EVAX $33.33
  • LGCB N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • LGCB 320.2K
  • Earning Date
  • EVAX 03-26-2025
  • LGCB 03-11-2025
  • Dividend Yield
  • EVAX N/A
  • LGCB N/A
  • EPS Growth
  • EVAX N/A
  • LGCB N/A
  • EPS
  • EVAX N/A
  • LGCB N/A
  • Revenue
  • EVAX $3,295,000.00
  • LGCB $10,289,681.00
  • Revenue This Year
  • EVAX $4,845.21
  • LGCB N/A
  • Revenue Next Year
  • EVAX $30.30
  • LGCB N/A
  • P/E Ratio
  • EVAX N/A
  • LGCB N/A
  • Revenue Growth
  • EVAX N/A
  • LGCB N/A
  • 52 Week Low
  • EVAX $2.22
  • LGCB $0.17
  • 52 Week High
  • EVAX $23.70
  • LGCB $5.71
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • LGCB 37.61
  • Support Level
  • EVAX $2.22
  • LGCB $0.22
  • Resistance Level
  • EVAX $4.05
  • LGCB $0.26
  • Average True Range (ATR)
  • EVAX 1.17
  • LGCB 0.03
  • MACD
  • EVAX 0.00
  • LGCB -0.01
  • Stochastic Oscillator
  • EVAX 6.99
  • LGCB 15.23

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides global e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, global store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier.

Share on Social Networks: